That's essential, since the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work. In other words, we have to know how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental process (jeff brown 2020 predictions). But now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to develop drugs that do what they're designed to do. This was a breakthrough practically nobody discovered. However it's going to have extensive ramifications for treating disease. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be plenty of financial investment opportunities in this space, too. Moving topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown market predictions). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it pulled back possibly considerably prior to going greater - jeff brown stock predictions. I have actually been covering bitcoin for a very long time now. One of the very first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary suggestion, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were mainly informing readers. But that's not the huge concern any longer. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So believe about that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. artificial intelligence. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are numerous great personal companies on the verge of striking the general public markets And I've been working on a brand-new method for you to invest even before these business go public.
This chance has been building over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to reserve your area for free.
Emma Walsh here, managing editor of the Diary. Regular Diary readers know that tech isn't our typical beat (first lady). And when it comes to tech investing, we leave it to the specialists. Luckily, we have numerous such professionals in our Rolodex. Our coworker Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing specialists we understand (democratic republic). In truth, he had numerous triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge picture and forecast what's just around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing exponential development and creating amazing opportunities for financiers. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. future report review. But in spite of what lots of readers might believe, this is a pattern that's simply getting going. Despite the fact that the COVID-19 pandemic interrupted supply chains in 2015, an impressive 250 million 5G-enabled gadgets were still sold.
And all of this ultimately resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown biotech stock). Losing 2 months of manufacturing and sales truly affects the number of 5G devices are sold in the fiscal year. When you consider all of that, offering 250 million units is amazing. More importantly, the hold-ups brought on by the pandemic developed a ton of suppressed demand. And that need is now going to be pushed into 2021. In reality, I predict that more than 500 million 5G devices will be delivered in 2021 - jeff brown biotech stock pick for 2020. And that's not my only 5G prediction When I've discussed 5G in the past, I have actually described its 3 various stages.
In Phase Two, 5G gadgets go on sale. 5G phones and other items start to reach consumers. And in Stage Three, 5G services start to be offered (genetic sequencer stock jeff brown). That's when we start to see applications working on 5G networks. Believe of things like massive multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Phase 3 by this summertime. This begins something of a virtuous cycle: The majority of people don't truly care about the technology. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In truth, 5G is going to open up a suite of extraordinary applications: self-driving vehicles, the Web of Things, robotic surgery, and more. All of these innovations need 5G. The investment opportunities moving forward will be huge. Stepping far from 5G, the next crucial innovation I foresee in 2021 is CRISPR genetic modifying. CRISPR means "clustered routinely interspaced brief palindromic repeat." It's a mouthful. But it's one of the most exciting developments in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software application.
The program can crash or not work properly. CRISPR utilizes a comparable idea but with our genetic code. "Typos" in our genome can cause disease. CRISPR can correct these "typos." For many years, CRISPR was mostly a specific niche technology that wasn't well understood. And during that time, there were actually just three companies running in this area. However things are altering. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're treating illness and seeing that this technology just works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and providing incredible returns. This entire market is efficiently a greenfield chance.
There's space for many companies to exist in this space. jeff brown stock predictions. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or 3 more genetic modifying business will hold their IPOs. Sticking to biotechnology, we are seeing amazing things happening at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its most current Alpha, Fold software can accurately anticipate the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That's important due to the fact that the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has actually been an experimental procedure. Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to create drugs that do what they're designed to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but a number of drug therapies produced utilizing this innovation. This was among those advancements that almost no one discovered. However it's going to have extensive implications for curing illness. And, obviously, there will be a lot of financial investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it drew back maybe substantially before going greater. I've been covering bitcoin for a long time now. Among the very first research reports I ever published was on bitcoin - tech predictions. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for any person who followed my suggestion. However at the time of that preliminary recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
But no one is asking that concern any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. jeff brown 2020 predictions. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the information depends on date as of February 2021, however we might not independently validate this claim. Provided Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an exact figure at this moment. Brown is best understood for his sage-like ability to select winning technology stocks. He spent more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an exceptional point of view on the market. He's always on the hunt for brand-new chances, and he shares a lot of his best choices in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an outstanding credibility as a stock-picker, and he successfully anticipated a few of the biggest economic events of the past twenty years. Although he doesn't appear to release his choices to the general public, the service's success is a direct indication of Brown's stock-picking expertise. Nobody on Wall Street gets it best whenever, however Jeff Brown's precise predictions have earned him legions of dedicated followers. That says a lot about his ability. The Future Report is released by Brownstone Research study, a popular financial research publisher. Brownstone Research study offers a number of research study services with a wide range of expertises - biotech stocks.
The company is likewise associated with Bonner & Partners, another well-respected research publisher - toxic tech 5 tech darlings. On its website, Brownstone states its objective is to provide retail investors with professional-grade research: "For too long, the best financial investment research has actually not been offered to individual financiers. It has been normally reserved for investment banks, hedge funds, private equity, and high-net-worth clients. brownstone research. The objective of Brownstone Research is to make that type of proprietary research study available to any financiers aiming to gain an edge in the markets. The objective is basic to provide special and lucrative investment research discovered nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise acts as the firm's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to offer its clients. After years of steady success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a household name throughout the majority of America. If you know even a little bit about the marketplace, you understand that he has a track record as a King Midas of sorts. jeff brown stock market prediction. Whatever he touches turns to gold! Jeff is well conscious of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In fact, Brown thinks S.A.V. jeff brown biotech stock. could be "the greatest pattern of the 2020s, and he's not alone. Inspect out these quotes from other popular S.A.V. bulls: Elon's next huge act will be weding two innovative technologies: expert system and electric automobiles. Musk hopes the mix will help him establish the very first fully-autonomous, self-driving automobiles ever. It's nothing short of the vehicle market's Holy Grail. As you understand, electrical vehicles and self-driving vehicle stocks have been huge this year, however the Wall Street machine has approved buzz without much tangible result. In spite of a drastic boost in competition over the past few years, Brown still believes Musk has the best possibility of putting it all together.
tech might be the magic string that ties it all together. S.A.V. means Shared Autonomous Car, and it could be the future of transportation. Basically, this innovation would enable you to rent your vehicle as an autonomous, self-driving taxi when you're not utilizing it. You simply get out of the vehicle and press a button on an app that tells the car to "sign up with the fleet." Next thing you know, you're unwinding on your sofa while your automobile shuttles ride-sharers around town. Best of all, you get to keep a significant chunk of the revenues. It sounds insane, but it might be closed than you believe.